Curative Effect of Moxifloxacin Solution Atomization Inhalation in Treatment COPD Combined with Reslpiratory Failure
	    		
		   		
		   			
		   		
	    	
    	 
    	10.13241/j.cnki.pmb.2017.23.040
   		
        
        	
        		- VernacularTitle:莫西沙星溶液雾化吸入治疗COPD合并呼吸衰竭的疗效
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Zongmin SHI
			        		
			        		;
		        		
		        		
		        		
			        		Yongzhen YANG
			        		
			        		;
		        		
		        		
		        		
			        		Guofang YIN
			        		
			        		;
		        		
		        		
		        		
			        		Yuanmei ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Deyu LUO
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Chronic pulmonary obstructive pulmonary disease;
			        		
			        		
			        		
				        		Respiratory failure;
			        		
			        		
			        		
				        		Moxifloxacin solution;
			        		
			        		
			        		
				        		Atomization inhalation;
			        		
			        		
			        		
				        		Curative effect
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Progress in Modern Biomedicine
	            		
	            		 2017;17(23):4568-4571
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective:To research the curative effect of moxifloxacin solution atomization inhalation in the treatment of chronic obstructive pulmonary disease (COPD) combined with respiratory failure.Methods:94 cases of COPD patients combined with respiratory failure from May 2014 to May 2016 were selected and divided into the control group(n=47) and the research group (n=47) acording to the lottery method,the control group received routine treatment,while the research group was treated based on the control group with moxifloxacin solution inhalation treatment.The curative effect,serum tumor necrosis factor-α(TNF-α),c-reactive protein (CRP) and interleukin 10 (IL-10),creatine phosphokinase (CK),aspertate aminotransferase (AST) levels,the blood oxygen partial pressure (PaO2),CO2 partial pressure (PaCO2),APACHE Ⅱ score and occurrence of adverse reactions were compared between two groups.Results:After treatment,the total effective rate of research group was higher than that of the control group (P<0.05).The serum levels of TNF alpha,CRP,PaCO2,CK,AST,APACHE Ⅱ score of research group were evidently lower than those of the control group (P<0.05).The serum levels ofIL-10,PaO2 of research group were evident higher than those of the control group (P<0.05).The occurrence of adverse reactions showed no differences between the two groups (P>0.05).Conclusion:Moxifloxacin solution atomization inhalation was effective in the treatment of COPD combined with respiratory failure,which might be related to the inhibition of inflammatory response,and improvment of breath.